Study of Ambrisentan in Participants With Pulmonary Hypertension
NCT00777920
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
140
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Hypertension
Interventions
DRUG:
Ambrisentan
Sponsor
Gilead Sciences